Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 2 (2005), Issue 3 (March)

1. Detection of B-RAF and N-RAS mutations in human melanoma.
   J Am Coll Surg, 200(3): 362-70. [Abstract] [Full-text]
2. Selective induction of apoptosis in murine skin carcinoma cells (CH72) by an ethanol extract of Lentinula edodes.
   Cancer Lett, 220(1): 21-8. [Abstract] [Full-text]
3. Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas.
   Eur J Cancer, 41(4): 531-8. [Abstract] [Full-text]
4. Pigmented cutaneous papillomatosis (pigmented epidermal nevus) in three pug dogs; histopathology, electron microscopy and analysis of viral DNA by the polymerase chain reaction.
   J Comp Pathol, 132(2): 132-8. [Abstract] [Full-text]
5. Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma.
   J Invest Dermatol, 124(3): 651-61. [Abstract] [Full-text]
6. High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1alpha and basic fibroblast growth factor-mediated mechanisms.
   J Invest Dermatol, 124(3): 638-43. [Abstract] [Full-text]
7. Quantification of melanoma micrometastases in sentinel lymph nodes using real-time RT-PCR.
   J Invest Dermatol, 124(3): 633-7. [Abstract] [Full-text]
8. Suprabasal induction of ornithine decarboxylase in adult mouse skin is sufficient to activate keratinocytes.
   J Invest Dermatol, 124(3): 602-14. [Abstract] [Full-text]
9. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
   J Invest Dermatol, 124(3): 505-13. [Abstract] [Full-text]
10. Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors.
    J Invest Dermatol, 124(3): 493-8. [Abstract] [Full-text]
11. UV exposure, genetic targets in melanocytic tumors and transgenic mouse models.
    Photochem Photobiol, 81(1): 52-64. [Abstract] [Full-text]
12. Inverse relationship between increased apoptosis and decreased skin cancer in UV-irradiated CD1d-/- mice.
    Photochem Photobiol, 81(1): 46-51. [Abstract] [Full-text]
13. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution.
    Pediatrics, 115(3): 649-54. [Abstract] [Full-text]
14. In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma.
    Eur J Radiol, 53(3): 506-13. [Abstract] [Full-text]
15. Primary Sézary syndrome commonly shows low-grade cytologic atypia and an absence of epidermotropism.
    Am J Clin Pathol, 123(4): 510-5. [Abstract] [Full-text]
16. The North Queensland "Sun-Safe Clothing" study: design and baseline results of a randomized trial to determine the effectiveness of sun-protective clothing in preventing melanocytic nevi.
    Am J Epidemiol, 161(6): 536-45. [Abstract] [Full-text]
17. Chemoprevention by Hippophae rhamnoides: effects on tumorigenesis, phase II and antioxidant enzymes, and IRF-1 transcription factor.
    Nutr Cancer, 51(1): 59-67. [Abstract] [Full-text]
18. Sebaceous carcinoma of the ocular region: a review.
    Surv Ophthalmol, 50(2): 103-22. [Abstract] [Full-text]
19. Photochemoprevention of ultraviolet B signaling and photocarcinogenesis.
    Mutat Res, 571(1): 153-73. [Abstract] [Full-text]
20. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis.
    Mutat Res, 571(1): 107-20. [Abstract] [Full-text]
21. Cellular and molecular events leading to the development of skin cancer.
    Mutat Res, 571(1): 91-106. [Abstract] [Full-text]
22. Dose-dependent effects of UVB-induced skin carcinogenesis in hairless p53 knockout mice.
    Mutat Res, 571(1): 81-90. [Abstract] [Full-text]
23. Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma.
    Mutat Res, 571(1): 65-79. [Abstract] [Full-text]
24. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
    Mutat Res, 571(1): 43-56. [Abstract] [Full-text]
25. The causes of skin cancer: a comprehensive review.
    Drugs Today (Barc), 41(1): 37-53. [Abstract] [Full-text]
26. A case of canine apocrine sweat gland adenoma, clear cell variant.
    Vet Pathol, 42(2): 215-8. [Abstract] [Full-text]
27. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells.
    Cancer Res, 65(5): 1800-7. [Abstract] [Full-text]
28. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
    Cancer Res, 65(5): 1783-91. [Abstract] [Full-text]
29. Skin carcinoma arising from donor cells in a kidney transplant recipient.
    Cancer Res, 65(5): 1755-60. [Abstract] [Full-text]
30. Human papillomaviruses and skin cancer.
    J Clin Virol, 32: S67-71. [Abstract] [Full-text]
31. Livedo reticularis associated with interferon alpha therapy in two melanoma patients.
    J Eur Acad Dermatol Venereol, 19(2): 252-4. [Abstract] [Full-text]
32. Bowen's carcinoma of the scrotal skin associated with human papillomavirus type 82.
    J Eur Acad Dermatol Venereol, 19(2): 232-5. [Abstract] [Full-text]
33. Reactive angioendotheliomatosis: is it 'intravascular histiocytosis'?
    J Eur Acad Dermatol Venereol, 19(2): 216-9. [Abstract] [Full-text]
34. Multinucleate cell angiohistiocytoma: a new case report.
    J Eur Acad Dermatol Venereol, 19(2): 208-11. [Abstract] [Full-text]
35. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
    J Eur Acad Dermatol Venereol, 19(2): 180-6. [Abstract] [Full-text]
36. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
    Photodermatol Photoimmunol Photomed, 21(2): 72-8. [Abstract] [Full-text]
37. Malignant melanoma in pregnancy. A population-based evaluation.
    Cancer, 103(6): 1217-26. [Abstract] [Full-text]
38. Impact of radiographic findings on prognosis for skin carcinoma with clinical perineural invasion.
    Cancer, 103(6): 1254-7. [Abstract] [Full-text]
39. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Clin Cancer Res, 11(5): 1990-8. [Abstract] [Full-text]
40. AEE788, a dual tyrosine kinase receptor inhibitor, induces endothelial cell apoptosis in human cutaneous squamous cell carcinoma xenografts in nude mice.
    Clin Cancer Res, 11(5): 1963-73. [Abstract] [Full-text]
41. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
    Clin Cancer Res, 11(5): 1835-41. [Abstract] [Full-text]
42. Radiofrequency ablation for tumor-related massive hematuria.
    J Vasc Interv Radiol, 16(3): 417-21. [Abstract] [Full-text]
43. Full thickness skin graft for nail unit reconstruction.
    J Hand Surg [Br], 30(2): 194-8. [Abstract] [Full-text]
44. Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors.
    J Am Acad Dermatol, 52(3): 468-73. [Abstract] [Full-text]
45. Germline fumarate hydratase mutations and evidence for a founder mutation underlying multiple cutaneous and uterine leiomyomata.
    J Am Acad Dermatol, 52(3): 410-6. [Abstract] [Full-text]
46. Familial mycosis fungoides: report of 6 kindreds and a study of the HLA system.
    J Am Acad Dermatol, 52(3): 393-402. [Abstract] [Full-text]
47. Uveal melanocytomas: genetic comparison with uveal and dermal melanomas.
    Arch Ophthalmol, 123(3): 377-80. [Abstract] [Full-text]
48. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma.
    Cancer Epidemiol Biomarkers Prev, 14(3): 562-6. [Abstract] [Full-text]
49. RalGDS is required for tumor formation in a model of skin carcinogenesis.
    Cancer Cell, 7(3): 219-26. [Abstract] [Full-text]
50. Fine-needle aspiration cytology of metastatic transitional cell carcinoma.
    Diagn Cytopathol, 32(4): 226-8. [Abstract] [Full-text]
51. Granular cell atypical fibroxanthoma.
    J Cutan Pathol, 32(4): 314-7. [Abstract] [Full-text]
52. Rhabdomyomatous mesenchymal hamartoma associated with nasofrontal meningocele and dermoid cyst.
    J Cutan Pathol, 32(4): 310-3. [Abstract] [Full-text]
53. Eccrine mucinous metaplasia associated with an apocrine cystadenoma.
    J Cutan Pathol, 32(4): 307-9. [Abstract] [Full-text]
54. Evaluation of surgical margins in melanocytic lesions: a survey among 152 dermatopathologists.
    J Cutan Pathol, 32(4): 293-9. [Abstract] [Full-text]
55. Lymphangioma-like Kaposi sarcoma.
    J Cutan Pathol, 32(4): 286-92. [Abstract] [Full-text]
56. Cutaneous lipomatous neurofibroma: characterization and frequency.
    J Cutan Pathol, 32(4): 274-9. [Abstract] [Full-text]
57. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma.
    J Cutan Pathol, 32(4): 268-73. [Abstract] [Full-text]
58. Type VII collagen is required for Ras-driven human epidermal tumorigenesis.
    Science, 307(5716): 1773-6. [Abstract] [Full-text]
59. Peptide vaccination after repeated resection of metastases can induce a prolonged relapse-free interval in melanoma patients.
    Int J Cancer, 114(6): 936-41. [Abstract] [Full-text]
60. V3 versican isoform expression alters the phenotype of melanoma cells and their tumorigenic potential.
    Int J Cancer, 114(6): 879-86. [Abstract] [Full-text]
61. In vivo assessment of melanocytic nests in nevi and melanomas by reflectance confocal microscopy.
    Mod Pathol, 18(4): 469-74. [Abstract] [Full-text]
62. Ezrin in primary cutaneous melanoma.
    Mod Pathol, 18(4): 503-10. [Abstract] [Full-text]
63. Effect of sunscreen and clothing on the number of melanocytic nevi in 1,812 German children attending day care.
    Am J Epidemiol, 161(7): 620-7. [Abstract] [Full-text]
64. Color-specific enhancement of digital photographs for identification of the extent of cutaneous malignancy.
    Arch Facial Plast Surg, 7(2): 135-7. [Abstract] [Full-text]
65. Biological effects of bexarotene in cutaneous T-cell lymphoma.
    Arch Dermatol, 141(3): 315-21. [Abstract] [Full-text]
66. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
    Arch Dermatol, 141(3): 305-11. [Abstract] [Full-text]
67. Hair follicle-derived blood vessels vascularize tumors in skin and are inhibited by Doxorubicin.
    Cancer Res, 65(6): 2337-43. [Abstract] [Full-text]
68. The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin.
    Cancer Res, 65(6): 2216-23. [Abstract] [Full-text]
69. Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis.
    Cancer Res, 65(6): 2054-8. [Abstract] [Full-text]
70. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations.
    Br J Plast Surg, 58(3): 348-52. [Abstract] [Full-text]
71. Malignant melanoma in a candidate for heart transplantation.
    Dermatology, 210(3): 233-6. [Abstract] [Full-text]
72. Changing trends in the number of deaths from nonmelanoma skin cancer in Japan, 1955-2000.
    Dermatology, 210(3): 206-10. [Abstract] [Full-text]
73. Targetoid hemosiderotic nevus. A trauma-induced simulator of malignant melanoma.
    Dermatology, 210(3): 200-5. [Abstract] [Full-text]
74. Incidence of xeroderma pigmentosum in Larkana, Pakistan: a 7-year study.
    Br J Dermatol, 152(3): 545-51. [Abstract] [Full-text]
75. Intralesional therapy with anti-CD20 monoclonal antibody rituximab: local and systemic efficacy in primary cutaneous B-cell lymphoma.
    Br J Dermatol, 152(3): 541-4. [Abstract] [Full-text]
76. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.
    Br J Dermatol, 152(3): 518-23. [Abstract] [Full-text]
77. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi--results from the NYU-LCMN registry.
    Br J Dermatol, 152(3): 512-7. [Abstract] [Full-text]
78. Predictions of skin cancer incidence in the Netherlands up to 2015.
    Br J Dermatol, 152(3): 481-8. [Abstract] [Full-text]
79. Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma.
    Br J Dermatol, 152(3): 435-43. [Abstract] [Full-text]
80. Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome.
    Am J Med Genet A, 134(3): 233-6. [Abstract] [Full-text]
81. A kindred with MYH-associated polyposis and pilomatricomas.
    Am J Med Genet A, 134(2): 212-4. [Abstract] [Full-text]
82. Histological features used in the diagnosis of melanoma are frequently found in benign melanocytic naevi.
    J Clin Pathol, 58(4): 409-12. [Abstract] [Full-text]
83. A second field metachronous Merkel cell carcinoma of the lip and the palatine tonsil confirmed by microarray-based comparative genomic hybridisation.
    Virchows Arch, 446(3): 278-86. [Abstract] [Full-text]
84. Selection for TRAIL resistance results in melanoma cells with high proliferative potential.
    FEBS Lett, 579(9): 1940-4. [Abstract] [Full-text]
85. Capillary hemangioma of the central nervous system: a comparative study with lobular capillary hemangioma of the skin.
    Acta Neuropathol (Berl), 109(2): 151-8. [Abstract] [Full-text]
86. Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques.
    J Chromatogr B Analyt Technol Biomed Life Sci, 819(1): 59-66. [Abstract] [Full-text]
87. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
    Mol Carcinog, 42(4): 213-21. [Abstract] [Full-text]
88. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
    J Clin Oncol, 23(10): 2346-57. [Abstract] [Full-text]
89. Merkel cell carcinoma: prognosis and treatment of patients from a single institution.
    J Clin Oncol, 23(10): 2300-9. [Abstract] [Full-text]
90. Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial.
    Am J Epidemiol, 161(8): 748-54. [Abstract] [Full-text]
91. Basal cell carcinoma of the eyelid in Finland during 1953-97.
    Acta Ophthalmol Scand, 83(2): 215-20. [Abstract] [Full-text]
92. Chfr is required for tumor suppression and Aurora A regulation.
    Nat Genet, 37(4): 401-6. [Abstract] [Full-text]
93. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
    Int J Cancer, 115(2): 248-55. [Abstract] [Full-text]
94. DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis.
    Int J Cancer, 115(2): 224-30. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.